Copyright
©2007 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jan 28, 2007; 13(4): 579-584
Published online Jan 28, 2007. doi: 10.3748/wjg.v13.i4.579
Published online Jan 28, 2007. doi: 10.3748/wjg.v13.i4.579
Recent IV-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: An open-label pilot study
Th Witthoeft, D Ludwig, University Hospital Schleswig-Holstein Campus Luebeck, Department of Medicine I, Division of Gastroenterology, Luebeck, Germany
M Fuchs, University Hospital Ulm, Department of Medicine I, Ulm, Germany
Author contributions: All authors contributed equally to the work.
Supported by Yamanouchi Pharma GmbH (now Astellas Pharma GmbH, Munich, Germany)
Correspondence to: Dr. Thomas Witthoeft, University Hospital Schleswig-Holstein Campus Luebeck, Dept. of Medicine I, Div. of Gastroenterology, Ratzeburger Allee 160, Luebeck 23538, Germany. witthoeft@uni-luebeck.de
Telephone: +49-451-5002351 Fax: +49-451-5003645
Received: October 24, 2006
Revised: July 25, 2006
Accepted: December 19, 2006
Published online: January 28, 2007
Revised: July 25, 2006
Accepted: December 19, 2006
Published online: January 28, 2007
Core Tip